{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:16:35Z","timestamp":1770704195385,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1007\/s11908-002-0062-7","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:57:41Z","timestamp":1180097861000},"page":"7-16","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of bacterial meningitis"],"prefix":"10.1007","volume":"4","author":[{"given":"Allan R.","family":"Tunkel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Michael","family":"Scheld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"62_CR1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(95)92844-8","volume":"346","author":"AR Tunkel","year":"1995","unstructured":"Tunkel AR, Scheld WM: Acute bacterial meningitis. Lancet 1995, 346:1675\u20131680.","journal-title":"Lancet"},{"key":"62_CR2","first-page":"959","volume-title":"Principles and Practice of Infectious Diseases","author":"AR Tunkel","year":"2000","unstructured":"Tunkel AR, Scheld WM: Acute meningitis. In Principles and Practice of Infectious Diseases, edn 5. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill-Livingstone; 2000:959\u2013997.","edition":"edn 5"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11908-001-0076-6","volume":"3","author":"WR Short","year":"2001","unstructured":"Short WR, Tunkel AR: Timing of administration of antimicrobial therapy in bacterial meningitis. Curr Infect Dis Rep 2001, 3:360\u2013364.","journal-title":"Curr Infect Dis Rep"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0196-0644(05)81314-9","volume":"22","author":"DA Talan","year":"1993","unstructured":"Talan DA, Zibulewsky J: Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med 1993, 22:1733\u20131738.","journal-title":"Ann Emerg Med"},{"key":"62_CR5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00004","volume":"129","author":"SI Aronin","year":"1998","unstructured":"Aronin SI, Peduzzi P, Quagliarello VJ: Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998, 129:862\u2013869. A retrospective cohort study of 269 adults with community-acquired bacterial meningitis to determine whether timing of antimicrobial administration influenced patient outcome. The authors found that patients who advanced to a high level of clinical severity after presentation to the emergency department and before initiation of antimicrobial therapy had a statistically significant higher risk of adverse clinical outcome compared with those who remained in their original prognostic stage.","journal-title":"Ann Intern Med"},{"key":"62_CR6","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"1997","unstructured":"National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, edn 4. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997: NCCLS Document M7-A4.","edition":"edn 4"},{"key":"62_CR7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199508243330803","volume":"333","author":"J Hofmann","year":"1995","unstructured":"Hofmann J, Cetron MS, Farley MM, et al.: The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995, 333:481\u2013486.","journal-title":"N Engl J Med"},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jama.1996.03530270046030","volume":"275","author":"DB Jernigan","year":"1996","unstructured":"Jernigan DB, Cetron MS, Breiman RF: Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP working group. JAMA 1996, 275:206\u2013209.","journal-title":"JAMA"},{"key":"62_CR9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","volume":"26","author":"GD Campbell","year":"1998","unstructured":"Campbell GD, Silberman R: Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1998, 26:1188\u20131195.","journal-title":"Clin Infect Dis"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/514783","volume":"28","author":"J Song","year":"1999","unstructured":"Song J, Lee NY, Ichiyama S, et al.: Spread of Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999, 28:1206\u20131211.","journal-title":"Clin Infect Dis"},{"key":"62_CR11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(98)07228-6","volume":"353","author":"Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN)","year":"1999","unstructured":"Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN): Prospective multicentre hospital surveillance of Streptococcus pneumoniae in India. Lancet 1999, 353:1216\u20131221.","journal-title":"Lancet"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/515220","volume":"28","author":"JC Butler","year":"1999","unstructured":"Butler JC, Cetron MS: Pneumococcal drug resistance: the new \"special enemy of old age\". Clin Infect Dis 1999, 28:730\u2013735.","journal-title":"Clin Infect Dis"},{"key":"62_CR13","first-page":"656","volume":"48","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention: Geographic variation in penicillin resistance in Streptococcus pneumoniae - selected sites, United States, 1997. MMWR 1997, 48:656\u2013661.","journal-title":"MMWR"},{"key":"62_CR14","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S0002-9343(98)00351-9","volume":"106","author":"MR Jacobs","year":"1999","unstructured":"Jacobs MR: Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am J Med 1999, 106:19S-25S.","journal-title":"Am J Med"},{"key":"62_CR15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CMR.11.4.628","volume":"11","author":"SL Kaplan","year":"1998","unstructured":"Kaplan SL, Mason EO: Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998, 11:628\u2013644. An excellent review of the approach to management of invasive pneumococcal infections, including meningitis, caused by strains that are resistant to penicillins and cephalosporins.","journal-title":"Clin Microbiol Rev"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0140-6736(92)90087-J","volume":"339","author":"IR Friedland","year":"1992","unstructured":"Friedland IR, Klugman KP: Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992, 339:405\u2013408.","journal-title":"Lancet"},{"key":"62_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/clinids\/21.1.234","volume":"21","author":"GR Ruiz-Irastorza","year":"1995","unstructured":"Ruiz-Irastorza GR, Garea C, Alonso JJ, et al.: Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis. Clin Infect Dis 1995, 21:234\u2013235.","journal-title":"Clin Infect Dis"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00006454-199608000-00027","volume":"15","author":"C Florez","year":"1996","unstructured":"Florez C, Silva G, Martin E: Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate. Pediatr Infect Dis J 1996, 15:723\u2013724.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9343(99)80271-X","volume":"102","author":"TR Pacheco","year":"1997","unstructured":"Pacheco TR, Cooper CK, Hardy DJ, et al.: Failure of cefotaxime in an adult with Streptococcus pneumoniae meningitis. Am J Med 1997, 102:303\u2013305.","journal-title":"Am J Med"},{"key":"62_CR20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/AAC.40.1.218","volume":"40","author":"PF Viladrich","year":"1996","unstructured":"Viladrich PF, Cabello HSC, Pallar R, et al.: High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996, 40:218\u2013220.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/AAC.41.9.1888","volume":"41","author":"IR Friedland","year":"1997","unstructured":"Friedland IR, Klugman KP: Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dose cefotaxime. Antimicrob Agents Chemother 1997, 41:1888\u20131891.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jac\/45.3.315","volume":"45","author":"C Cabellos","year":"2000","unstructured":"Cabellos C, Martinez-Lacasa J, Tubau F, et al.: Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother 2000, 45:315\u2013320.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/45.1.63","volume":"45","author":"CM Gerber","year":"2000","unstructured":"Gerber CM, Cottagnoud M, Neftel K, et al.: Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. J Antimicrob Chemother 2000, 45:63\u201368.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/AAC.35.12.2467","volume":"35","author":"PF Viladrich","year":"1991","unstructured":"Viladrich PF, Gudiol F, Linares J, et al.: Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991, 35:2467\u20132472.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00006454-199709000-00014","volume":"16","author":"A Ahmed","year":"1997","unstructured":"Ahmed A: A critical evaluation of vancomycin for treatment of bacterial meningitis. Pediatr Infect Dis J 1997, 16:895\u2013903.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.38.6.1320","volume":"38","author":"MM Paris","year":"1994","unstructured":"Paris MM, Hickey SM, Uscher MI, et al.: Effect of dexamethasone on therapy of experimental penicillin- and cephalosporinresistant pneumococcal meningitis. Antimicrob Agents Chemother 1994, 38:1320\u20131324.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR27","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/AAC.39.9.2158","volume":"39","author":"C Cabellos","year":"1995","unstructured":"Cabellos C, Martinez-Lacasa J, Martos A, et al.: Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995, 39:2158\u20132160.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/21202","volume":"399","author":"R Novak","year":"1999","unstructured":"Novak R, Henriques B, Charpentier E, et al.: Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999, 399:590\u2013593. An interesting report describing tolerance of S. pneumoniae to vancomycin.","journal-title":"Nature"},{"key":"62_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/315216","volume":"181","author":"JA McCullers","year":"2000","unstructured":"McCullers JA, English BK, Novak R: Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 2000, 181:369\u2013373. A case report describing a patient with pneumococcal meningitis caused by a vancomcyin-tolerant strain; the patient developed recrudescence of meningitis despite therapy with vancomycin plus a third-generation cephalosporin.","journal-title":"J Infect Dis"},{"key":"62_CR30","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/314760","volume":"179","author":"R Nau","year":"1999","unstructured":"Nau R, Wellmer A, Soto A, et al.: Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis 1999, 179:1557\u20131560.","journal-title":"J Infect Dis"},{"key":"62_CR31","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/AAC.43.10.2372","volume":"43","author":"F Fitoussi","year":"1999","unstructured":"Fitoussi F, Doit C, Geslin P, Bingen E: Killing activities of trovafloxacin alone and in combination with b-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid. Antimicrob Agents Chemother 1999, 43:2372\u20132375.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/514777","volume":"28","author":"RJ Stanek","year":"1999","unstructured":"Stanek RJ, Mufson MA: A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis 1999, 28:1265\u20131272.","journal-title":"Clin Infect Dis"},{"key":"62_CR33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1542\/peds.102.5.1087","volume":"102","author":"M Arditi","year":"1998","unstructured":"Arditi M, Mason EO Jr, Bradley JS, et al.: Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998, 102:1087\u20131097. A multicenter, retrospective study of 180 episodes of pneumococcal meningitis in children, in which the mortality and frequency of neurologic sequelae were not influenced by the susceptibility of the pneumococcal isolate to penicillin or ceftriaxone.","journal-title":"Pediatrics"},{"key":"62_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/313606","volume":"30","author":"AE Fiore","year":"2000","unstructured":"Fiore AE, Moroney JF, Farley MM, et al.: Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000, 30:71\u201377.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"62_CR35","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/clinids\/24.Supplement_2.S213","volume":"24","author":"JS Bradley","year":"1997","unstructured":"Bradley JS, Scheld WM: The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis 1997, 24(Suppl 2):S213-S221.","journal-title":"Clin Infect Dis"},{"key":"62_CR36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00006454-199907000-00004","volume":"18","author":"CM Odio","year":"1999","unstructured":"Odio CM, Puig JR, Feris JM, et al.: Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Pediatr Infect Dis J 1999, 18:581\u2013590. A prospective study comparing meropenem to cefotaxime in 258 children with bacterial meningitis; cure rates were similar in both groups.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00006454-199710000-00026","volume":"16","author":"CC John","year":"1997","unstructured":"John CC, Aouad G, Berman B, Schreiber JR: Successful meropenem treatment of multiply resistant pneumococcal meningitis. Pediatr Infect Dis J 1997, 16:1009\u20131011.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/45.1.5","volume":"45","author":"AR Norrby","year":"2000","unstructured":"Norrby AR: Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrob Chemother 2000, 45:5\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/AAC.43.4.963","volume":"43","author":"D Rodoni","year":"1999","unstructured":"Rodoni D, Hanni F, Gerber CM, et al.: Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother 1999, 43:963\u2013965.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/AAC.42.6.1397","volume":"42","author":"H Schmidt","year":"1998","unstructured":"Schmidt H, Dalhoff A, Stuertz K, et al.: Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother 1998, 42:1397\u20131401.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/AAC.42.7.1706","volume":"42","author":"C Ostergaard","year":"1998","unstructured":"Ostergaard C, Sorensen TK, Knudsen JD, Frimodt-Moller N: Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother 1998, 42:1706\u20131712.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0891-5520(05)70254-3","volume":"14","author":"MH Chowdhury","year":"2000","unstructured":"Chowdhury MH, Tunkel AR: Antibacterial agents in infections of the central nervous system. Infect Dis Clin North Am 2000, 14:391\u2013408.","journal-title":"Infect Dis Clin North Am"},{"key":"62_CR43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/313557","volume":"29","author":"GW Wortmann","year":"1999","unstructured":"Wortmann GW, Bennett SP: Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae. Clin Infect Dis 1999, 29:1599\u20131600.","journal-title":"Clin Infect Dis"},{"key":"62_CR44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/clinids\/14.2.394","volume":"14","author":"JA Saez-Nieto","year":"1992","unstructured":"Saez-Nieto JA, Lujan R, Berron S, et al.: Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis 1992, 14:394\u2013402.","journal-title":"Clin Infect Dis"},{"key":"62_CR45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144","volume":"13","author":"M Deuren van","year":"2000","unstructured":"van Deuren M, Brandtzaeg P, van der Meer JWM: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000, 13:144\u2013166.","journal-title":"Clin Microbiol Rev"},{"key":"62_CR46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/infdis\/169.2.438","volume":"169","author":"LA Jackson","year":"1994","unstructured":"Jackson LA, Tenover FC, Baker C, et al.: Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. J Infect Dis 1994, 169:438\u2013441.","journal-title":"J Infect Dis"},{"key":"62_CR47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1086\/313599","volume":"30","author":"NE Rosenstein","year":"2000","unstructured":"Rosenstein NE, Stocker SA, Popovic T, et al.: Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin Infect Dis 2000, 30:212\u2013213. A population-based survey of seven geographically dispersed areas of the United States during 1997, in which three of 90 meningococcal isolates were intermediately resistant to penicillin (MIC 0.12 \u29ceg\/mL).","journal-title":"Clin Infect Dis"},{"key":"62_CR48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/516994","volume":"25","author":"J Casado-Flores","year":"1997","unstructured":"Casado-Flores J, Osona B, Comingo P, Barquet N: Meningococcal meningitis during penicillin therapy for meningococcemia. Clin Infect Dis 1997, 25:1479.","journal-title":"Clin Infect Dis"},{"key":"62_CR49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1086\/517128","volume":"26","author":"LZ Goldani","year":"1998","unstructured":"Goldani LZ: Inducement of Neisseria meningitidis resistance to ampicillin and penicillin in a patient with meningococcemia treated with high doses of ampicillin. Clin Infect Dis 1998, 26:772.","journal-title":"Clin Infect Dis"},{"key":"62_CR50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.1997.tb08826.x","volume":"86","author":"CL Cubells","year":"1997","unstructured":"Cubells CL, Garcia JJG, Martinez JR, Otin CL: Clinical data in children with meningococcal meningitis in a Spanish hospital. Acta Paediatr 1997, 86:26\u201329.","journal-title":"Acta Paediatr"},{"key":"62_CR51","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199809243391302","volume":"339","author":"M Galimand","year":"1998","unstructured":"Galimand M, Gerbaud G, Guibourdenche M, et al.: High-level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med 1998, 339:868\u2013874. A description of high-level chloramphenicol resistance (MIC \u00dd 64 \u29ceg\/ mL) among strains of N. meningitidis. Resistance resulted from the presence of the catP gene on a truncated transposon that lost mobility because of internal deletions.","journal-title":"N Engl J Med"},{"key":"62_CR52","unstructured":"Hopkins S, Williams D, Dunne M, et al.: A randomized, controlled trial of oral or IV trovafloxacin vs. ceftriaxone in the treatment of epidemic meningococcal meningitis. Paper presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC.,1996."},{"key":"62_CR53","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0140-6736(92)90714-E","volume":"339","author":"JP Donnelly","year":"1992","unstructured":"Donnelly JP, Horrevorts AM, Sauerwein RW, et al.: High-dose meropenem in meningitis due to Pseudomonas aeruginosa. Lancet 1992, 339:1117.","journal-title":"Lancet"},{"key":"62_CR54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/32.6.922","volume":"32","author":"V Chmelik","year":"1993","unstructured":"Chmelik V, Gutvirth J: Meropenem treatment of posttraumatic meningitis due to Pseudomonas aeruginosa. J Antimicrob Chemother 1993, 32:922\u2013923.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR55","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/514754","volume":"28","author":"S Segal-Maurer","year":"1999","unstructured":"Segal-Maurer S, Mariano N, Qavi A, et al.: Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review. Clin Infect Dis 1999, 28:1134\u20131138.","journal-title":"Clin Infect Dis"},{"key":"62_CR56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365549850160774","volume":"30","author":"ML Nunez","year":"1998","unstructured":"Nunez ML, Martinez-Toldos C, Bru M, et al.: Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter. Scand J Infect Dis 1998, 30:421\u2013423.","journal-title":"Scand J Infect Dis"},{"key":"62_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0732-8893(99)00052-8","volume":"35","author":"V Kremery Jr","year":"1999","unstructured":"Kremery V Jr, Filka J, Uher J, et al.: Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. Diag Microbiol Infect Dis 1999, 35:75\u201380.","journal-title":"Diag Microbiol Infect Dis"},{"key":"62_CR58","first-page":"27","volume":"40","author":"CH Lu","year":"1998","unstructured":"Lu CH, Chang WN, Chuang YC, Chang HW: The prognostic factors of adult gram-negative bacillary meningitis. J Hosp Infect 1998, 40:27\u201334.","journal-title":"J Hosp Infect"},{"key":"62_CR59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00006454-199502000-00001","volume":"14","author":"JA Waler","year":"1995","unstructured":"Waler JA, Rathore MH: Outpatient management of pediatric bacterial meningitis. Pediatr Infect Dis J 1995, 14:89\u201392.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR60","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/313503","volume":"29","author":"AD Tice","year":"1999","unstructured":"Tice AD, Strait K, Ramey R, Hoaglund PA: Outpatient parenteral antimicrobial therapy for central nervous system infections. Clin Infect Dis 1999, 29:1394\u20131399. An excellent overview of the indications and recommendations for use of outpatient antimicrobial therapy for treatment of bacterial meningitis and other central nervous system infections.","journal-title":"Clin Infect Dis"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-002-0062-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0062-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:21:55Z","timestamp":1559434915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-002-0062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s11908-002-0062-7","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}